Targeted radiation zaps inoperable liver tumors in new trial
NCT ID NCT07110233
Summary
This study is testing a targeted radiation treatment for people with early-stage liver cancer that cannot be removed by surgery. Doctors will inject tiny radioactive beads directly into the blood vessels feeding the tumor to deliver a high dose of radiation. The main goals are to see how well the treatment shrinks the tumors and to monitor its safety and impact on patients' quality of life and survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.